Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment

WCK 5222 is a novel β-lactam–β-lactam-enhancer combination of cefepime (FEP) and zidebactam (ZID). ZID is a novel β-lactam enhancer with a dual action of binding to Gram-negative penicillin-binding protein 2 (PBP2) and β-lactamase inhibition. WCK 5222 is being developed as a new therapeutic option f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Preston, Richard A., Mamikonyan, Grigor, DeGraff, Stephane, Chiou, James, Kemper, Christopher J., Xu, Allan, Mastim, Mushtaque, Yeole, Ravindra, Chavan, Rajesh, Patel, Anasuya, Friedland, H. David, Bhatia, Ashima
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2018
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325229/
https://ncbi.nlm.nih.gov/pubmed/30397067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01484-18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares